These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19494653)

  • 1. Neuroprotection for diabetic retinopathy.
    Imai H; Singh RSJ; Fort PE; Gardner TW
    Dev Ophthalmol; 2009; 44():56-68. PubMed ID: 19494653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotection as a Therapeutic Target for Diabetic Retinopathy.
    Hernández C; Dal Monte M; Simó R; Casini G
    J Diabetes Res; 2016; 2016():9508541. PubMed ID: 27123463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodegeneration and Neuroinflammation in Diabetic Retinopathy: Potential Approaches to Delay Neuronal Loss.
    Kadłubowska J; Malaguarnera L; Wąż P; Zorena K
    Curr Neuropharmacol; 2016; 14(8):831-839. PubMed ID: 27306035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodegeneration in diabetic retinopathy: does it really matter?
    Simó R; Stitt AW; Gardner TW
    Diabetologia; 2018 Sep; 61(9):1902-1912. PubMed ID: 30030554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Mechanisms Mediating Diabetic Retinal Neurodegeneration: Potential Research Avenues and Therapeutic Targets.
    Chakravarthy H; Devanathan V
    J Mol Neurosci; 2018 Nov; 66(3):445-461. PubMed ID: 30293228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal Neurodegeneration as an Early Manifestation of Diabetic Eye Disease and Potential Neuroprotective Therapies.
    Zafar S; Sachdeva M; Frankfort BJ; Channa R
    Curr Diab Rep; 2019 Feb; 19(4):17. PubMed ID: 30806815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection in diabetic retinopathy.
    Hernández C; Simó R
    Curr Diab Rep; 2012 Aug; 12(4):329-37. PubMed ID: 22581259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic retinopathy: neuron protection as a therapeutic target.
    Zhang X; Wang N; Barile GR; Bao S; Gillies M
    Int J Biochem Cell Biol; 2013 Jul; 45(7):1525-9. PubMed ID: 23506699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the neuroprotective drugs somatostatin and brimonidine on retinal cell models of diabetic retinopathy.
    Beltramo E; Lopatina T; Mazzeo A; Arroba AI; Valverde AM; Hernández C; Simó R; Porta M
    Acta Diabetol; 2016 Dec; 53(6):957-964. PubMed ID: 27552833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives.
    Simó R; Hernández C;
    Trends Endocrinol Metab; 2014 Jan; 25(1):23-33. PubMed ID: 24183659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications.
    Simó R; Hernández C;
    Br J Ophthalmol; 2012 Oct; 96(10):1285-90. PubMed ID: 22887976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin replacement: a new strategy for treating diabetic retinopathy.
    Hernández C; Simó R;
    Curr Med Chem; 2013; 20(26):3251-7. PubMed ID: 23745546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spermine oxidase: A promising therapeutic target for neurodegeneration in diabetic retinopathy.
    Narayanan SP; Shosha E; D Palani C
    Pharmacol Res; 2019 Sep; 147():104299. PubMed ID: 31207342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodegeneration in diabetic retinopathy: Potential for novel therapies.
    Barber AJ; Baccouche B
    Vision Res; 2017 Oct; 139():82-92. PubMed ID: 28988945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroretinal Apoptosis as a Vascular Dysfunction in Diabetic Patients.
    Mrugacz M; Bryl A; Bossowski A
    Curr Neuropharmacol; 2016; 14(8):826-830. PubMed ID: 27212050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Emphasizes the research of diabetic retinal neurons lesions and retinal neuroprotection].
    Zhang MN
    Zhonghua Yan Ke Za Zhi; 2009 May; 45(5):385-8. PubMed ID: 19576057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Of neurons and pericytes: The neuro-vascular approach to diabetic retinopathy.
    Eleftheriou CG; Ivanova E; Sagdullaev BT
    Vis Neurosci; 2020 Aug; 37():E005. PubMed ID: 32778188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical Administration of GLP-1 Receptor Agonists Prevents Retinal Neurodegeneration in Experimental Diabetes.
    Hernández C; Bogdanov P; Corraliza L; García-Ramírez M; Solà-Adell C; Arranz JA; Arroba AI; Valverde AM; Simó R
    Diabetes; 2016 Jan; 65(1):172-87. PubMed ID: 26384381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morphological changes in retinal neurons in rats with streptozotocin diabetes and their correction by O-isobornylphenol derivative].
    Logvinov SV; Plotnikov MB; Zhdankina AA; Smol'iakova VI; Ivanov IS; Kuchin AV; Chukicheva IV; Varakuta EIu
    Morfologiia; 2009; 136(5):42-5. PubMed ID: 20210096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological changes in retinal neurons in streptozotocin-induced diabetes mellitus and their correction with an isobornylphenol derivative.
    Logvinov SV; Plotnikov MB; Zhdankina AA; Smolyakova VI; Ivanov IS; Kuchin AV; Chukicheva IV; Varakuta EY
    Neurosci Behav Physiol; 2010 Sep; 40(7):779-82. PubMed ID: 20635211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.